Some of it makes sense, but $A becoming less favourable for US buyers, and US$ income in $A going down.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025